MLTX NASDAQ
MoonLake Immunotherapeutics
1W: +21.1%
1M: -1.9%
3M: -36.9%
YTD: -1.2%
1Y: +24.8%
3Y: -79.0%
5Y: +18.1%
$11.93
+0.12 (+1.02%)
After Hours: $12.21 (+0.28, +2.31%)
Weekly Expected Move ±10.7%
$9
$11
$12
$13
$14
Credit Risk of going bust: higher than 60% of companies Debt: 9.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.16 (down 99%), MoonLake Immunotherapeutics would be worth roughly what it owes.
Total debt $101.5M against a stock market value of $1.01B.
Distance to default 4.27 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $49.8M (short-term plus half of long-term), stock volatility 70.4%; Altman Z'' 2.73. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $101.5M against a stock market value of $1.01B.
Distance to default 4.27 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $49.8M (short-term plus half of long-term), stock volatility 70.4%; Altman Z'' 2.73. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ETF Exposure
19
ETFs Holding
Total ETF Value
1.64%
Max Weight
0.140%
Avg Weight
ETF Holdings by Value
ETFs Holding MLTX
| # | ETF | Weight | Value | Holdings | Top 10 Wt | P/E | Div Yield | Sector Mix |
|---|---|---|---|---|---|---|---|---|
| 1 |
TCAF
T. Rowe Capital Appreciation Equity ETF
|
0.0317% | 92 | 38.8% | 37.8 | 0.01% | ||
| 2 | FBIOX | 0.0340% | 165 | 45.1% | -5.9 | 0.01% | ||
| 3 | SHISX | 0.0301% | 106 | 44.1% | 34.1 | 0.01% | ||
| 4 | SHSAX | 0.0301% | 106 | 44.1% | 34.1 | 0.01% | ||
| 5 | SHSCX | 0.0301% | 106 | 44.1% | 34.1 | 0.01% | ||
| 6 | SHSKX | 0.0301% | 106 | 44.1% | 34.1 | 0.01% | ||
| 7 | SHSSX | 0.0301% | 127 | 52.0% | 26.8 | 0.01% | ||
| 8 | BHSRX | 0.0301% | 106 | 44.1% | 34.1 | 0.01% | ||
| 9 |
VHT
Vanguard Health Care ETF
|
0.0072% | 410 | 51.8% | 30.6 | 0.01% | ||
| 10 | VHCIX | 0.0072% | 394 | 51.9% | 30.6 | 0.01% | ||
| 11 | FNCMX | 0.0040% | 2,781 | 57.5% | 72.7 | 0.27% | ||
| 12 |
ESML
iShares ESG Aware MSCI USA Small-Cap ETF
|
0.0377% | 897 | 5.1% | 20.0 | 0.01% | ||
| 13 |
TMED
T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF
|
1.6366% | 111 | 38.8% | 15.7 | 0.00% | ||
| 14 |
NUSC
Nuveen ESG Small-Cap ETF
|
0.0401% | 392 | 10.1% | 13.9 | 0.02% | ||
| 15 |
GWX
State Street SPDR S&P International Small Cap ETF
|
0.0506% | 2,011 | 2.0% | 19.2 | 0.03% | ||
| 16 |
OPTZ
Optimize Strategy Index ETF
|
0.1500% | 393 | 12.7% | 38.7 | 0.01% | ||
| 17 |
ONEQ
Fidelity Nasdaq Composite Index ETF
|
—% | 997 | 56.9% | 92.9 | 0.01% | ||
| 18 |
FHLC
Fidelity MSCI Health Care Index ETF
|
0.0100% | 333 | 52.1% | 31.2 | 0.01% | ||
| 19 |
BBC
Virtus Biotech Clinical Trials ETF
|
0.5100% | 129 | 15.2% | -15.5 | —% | ||
| 20 |
WSML
iShares MSCI World Small-Cap ETF
|
0.0057% | 3,661 | 2.5% | 20.4 | 0.02% | ||
| 21 |
MSML
iShares MSCI USA Small-Cap ETF
|
0.0100% | 1,657 | 4.0% | 21.1 | 0.02% | ||
| 22 |
KBFR
Innovator U.S. Small Cap Managed 10 Buffer ETF
|
0.0600% | 819 | 3.1% | 6.8 | 0.02% | ||
| 23 |
JKJ
iShares Morningstar Small-Cap ETF
|
0.0100% | 1,661 | 4.2% | 20.8 | 0.01% |
Tech
Financial
Healthcare
Consumer Cycl.
Industrials
Energy